A | B | C | |
---|---|---|---|
1 | Main | ||
2 | Brand Name | Doribax | |
3 | Generic Name | doripenem | |
4 | Indication | cUTI and cIAI | |
5 | Class | carbapenem | |
6 | Mechanism | active against a wide range of Gram-positive and Gram-negative bacterias | |
7 | Administration | IV | |
8 | Timeline | HAP complete response letter received 8/21/08. | |
9 | Clinical Trials | ||
10 | |||
11 | 83% clinical cure rate in patients with complicated intra-abdominal infections | ||
12 | n=486 (315 microbiologically evaluable), 83.3% doripenem cure rate and 83% for meropenem | ||
13 | 9.5% nausea, 7.4% diarrhea, 7% anemia, 6.6% vomiting |